Do analysts rate BLCO or UFPT?

Bausch + Lomb currently has a consensus target price of $18.75, indicating a potential upside of 12.04%. Given Bausch + Lomb's stronger consensus rating and higher possible upside, research analysts plainly believe Bausch + Lomb is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch + Lomb 1 Sell rating(s) 8 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.29 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to BLCO or UFPT?

In the previous week, UFP Technologies had 4 more articles in the media than Bausch + Lomb. MarketBeat recorded 23 mentions for UFP Technologies and 19 mentions for Bausch + Lomb. UFP Technologies' average media sentiment score of 0.74 beat Bausch + Lomb's score of 0.27 indicating that UFP Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bausch + Lomb 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral UFP Technologies 10 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend MMSI or UFPT?

Merit Medical Systems presently has a consensus price target of $100.30, indicating a potential upside of 12.65%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, research analysts clearly believe Merit Medical Systems is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Merit Medical Systems 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer MMSI or UFPT?

In the previous week, UFP Technologies had 11 more articles in the media than Merit Medical Systems. MarketBeat recorded 23 mentions for UFP Technologies and 12 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.80 beat UFP Technologies' score of 0.74 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 5 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UFP Technologies 10 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate NVST or UFPT?

Envista currently has a consensus target price of $29.31, suggesting a potential upside of 3.86%. Given Envista's stronger consensus rating and higher probable upside, analysts clearly believe Envista is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envista 0 Sell rating(s) 10 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.38 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to NVST or UFPT?

In the previous week, UFP Technologies had 5 more articles in the media than Envista. MarketBeat recorded 23 mentions for UFP Technologies and 18 mentions for Envista. UFP Technologies' average media sentiment score of 0.74 beat Envista's score of 0.65 indicating that UFP Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 5 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UFP Technologies 10 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ICUI or UFPT?

ICU Medical currently has a consensus target price of $192.80, suggesting a potential upside of 4.46%. Given ICU Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe ICU Medical is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ICU Medical 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.89 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to ICUI or UFPT?

In the previous week, ICU Medical had 4 more articles in the media than UFP Technologies. MarketBeat recorded 27 mentions for ICU Medical and 23 mentions for UFP Technologies. ICU Medical's average media sentiment score of 0.97 beat UFP Technologies' score of 0.74 indicating that ICU Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ICU Medical 13 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UFP Technologies 10 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer XRAY or UFPT?

DENTSPLY SIRONA presently has a consensus price target of $13.54, indicating a potential upside of 11.70%. Given DENTSPLY SIRONA's higher probable upside, research analysts clearly believe DENTSPLY SIRONA is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DENTSPLY SIRONA 3 Sell rating(s) 9 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.00 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer XRAY or UFPT?

In the previous week, UFP Technologies had 3 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 23 mentions for UFP Technologies and 20 mentions for DENTSPLY SIRONA. UFP Technologies' average media sentiment score of 0.74 beat DENTSPLY SIRONA's score of 0.54 indicating that UFP Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 7 Very Positive mention(s) 0 Positive mention(s) 9 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive UFP Technologies 10 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

UFP Technologies (UFPT) Competitors

$314.01 +2.14 (+0.69%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$313.83 -0.18 (-0.06%)

As of 08/7/2026 07:34 PM Eastern

Compare

UFPT vs. BLCO, MMSI, NVST, ICUI, and XRAY

Should you buy UFP Technologies stock or one of its competitors? MarketBeat compares UFP Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with UFP Technologies include Bausch + Lomb (BLCO), Merit Medical Systems (MMSI), Envista (NVST), ICU Medical (ICUI), and DENTSPLY SIRONA (XRAY). These companies are all part of the "healthcare supplies" industry.

How does UFP Technologies compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Bausch + Lomb has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market.

UFP Technologies has a net margin of 11.45% compared to Bausch + Lomb's net margin of -3.21%. UFP Technologies' return on equity of 18.42% beat Bausch + Lomb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch + Lomb	-3.21%	4.14%	1.93%
UFP Technologies	11.45%	18.42%	11.96%

11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 87.3% of UFP Technologies shares are held by institutional investors. 1.5% of Bausch + Lomb shares are held by insiders. Comparatively, 4.6% of UFP Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, UFP Technologies had 4 more articles in the media than Bausch + Lomb. MarketBeat recorded 23 mentions for UFP Technologies and 19 mentions for Bausch + Lomb. UFP Technologies' average media sentiment score of 0.74 beat Bausch + Lomb's score of 0.27 indicating that UFP Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bausch + Lomb	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
UFP Technologies	10 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Bausch + Lomb currently has a consensus target price of $18.75, indicating a potential upside of 12.04%. Given Bausch + Lomb's stronger consensus rating and higher possible upside, research analysts plainly believe Bausch + Lomb is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch + Lomb	1 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.29
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

UFP Technologies has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch + Lomb	$5.10B	1.17	-$360M	-$0.48	N/A
UFP Technologies	$602.80M	4.03	$68.31M	$9.28	33.84

Summary

UFP Technologies beats Bausch + Lomb on 12 of the 16 factors compared between the two stocks.

How does UFP Technologies compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment.

Merit Medical Systems has higher revenue and earnings than UFP Technologies. UFP Technologies is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	3.51	$128.49M	$2.42	36.79
UFP Technologies	$602.80M	4.03	$68.31M	$9.28	33.84

UFP Technologies has a net margin of 11.45% compared to Merit Medical Systems' net margin of 9.22%. UFP Technologies' return on equity of 18.42% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.22%	13.75%	8.10%
UFP Technologies	11.45%	18.42%	11.96%

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 87.3% of UFP Technologies shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 4.6% of UFP Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Merit Medical Systems has a beta of 0.49, meaning that its share price is 51% less volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market.

In the previous week, UFP Technologies had 11 more articles in the media than Merit Medical Systems. MarketBeat recorded 23 mentions for UFP Technologies and 12 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.80 beat UFP Technologies' score of 0.74 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	5 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UFP Technologies	10 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Merit Medical Systems presently has a consensus price target of $100.30, indicating a potential upside of 12.65%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, research analysts clearly believe Merit Medical Systems is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Merit Medical Systems and UFP Technologies tied by winning 8 of the 16 factors compared between the two stocks.

How does UFP Technologies compare to Envista?

Envista (NYSE:NVST) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership.

Envista has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market.

Envista currently has a consensus target price of $29.31, suggesting a potential upside of 3.86%. Given Envista's stronger consensus rating and higher probable upside, analysts clearly believe Envista is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

UFP Technologies has a net margin of 11.45% compared to Envista's net margin of 3.33%. UFP Technologies' return on equity of 18.42% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	3.33%	7.88%	4.33%
UFP Technologies	11.45%	18.42%	11.96%

87.3% of UFP Technologies shares are held by institutional investors. 1.0% of Envista shares are held by company insiders. Comparatively, 4.6% of UFP Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, UFP Technologies had 5 more articles in the media than Envista. MarketBeat recorded 23 mentions for UFP Technologies and 18 mentions for Envista. UFP Technologies' average media sentiment score of 0.74 beat Envista's score of 0.65 indicating that UFP Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	5 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UFP Technologies	10 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

UFP Technologies has lower revenue, but higher earnings than Envista. UFP Technologies is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.69	$47M	$0.41	68.83
UFP Technologies	$602.80M	4.03	$68.31M	$9.28	33.84

Summary

UFP Technologies beats Envista on 11 of the 16 factors compared between the two stocks.

How does UFP Technologies compare to ICU Medical?

ICU Medical (NASDAQ:ICUI) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.

ICU Medical has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.08, suggesting that its share price is 8% more volatile than the broader market.

UFP Technologies has lower revenue, but higher earnings than ICU Medical. UFP Technologies is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.23B	2.07	$730K	$1.85	99.76
UFP Technologies	$602.80M	4.03	$68.31M	$9.28	33.84

ICU Medical currently has a consensus target price of $192.80, suggesting a potential upside of 4.46%. Given ICU Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe ICU Medical is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 87.3% of UFP Technologies shares are owned by institutional investors. 2.1% of ICU Medical shares are owned by insiders. Comparatively, 4.6% of UFP Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

UFP Technologies has a net margin of 11.45% compared to ICU Medical's net margin of 1.39%. UFP Technologies' return on equity of 18.42% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ICU Medical	1.39%	7.94%	4.15%
UFP Technologies	11.45%	18.42%	11.96%

In the previous week, ICU Medical had 4 more articles in the media than UFP Technologies. MarketBeat recorded 27 mentions for ICU Medical and 23 mentions for UFP Technologies. ICU Medical's average media sentiment score of 0.97 beat UFP Technologies' score of 0.74 indicating that ICU Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ICU Medical	13 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UFP Technologies	10 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

ICU Medical beats UFP Technologies on 9 of the 17 factors compared between the two stocks.

How does UFP Technologies compare to DENTSPLY SIRONA?

DENTSPLY SIRONA (NASDAQ:XRAY) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations.

UFP Technologies has a net margin of 11.45% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.74% beat UFP Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.74%	5.26%
UFP Technologies	11.45%	18.42%	11.96%

In the previous week, UFP Technologies had 3 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 23 mentions for UFP Technologies and 20 mentions for DENTSPLY SIRONA. UFP Technologies' average media sentiment score of 0.74 beat DENTSPLY SIRONA's score of 0.54 indicating that UFP Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	7 Very Positive mention(s)	0 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
UFP Technologies	10 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DENTSPLY SIRONA has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market.

DENTSPLY SIRONA presently has a consensus price target of $13.54, indicating a potential upside of 11.70%. Given DENTSPLY SIRONA's higher probable upside, research analysts clearly believe DENTSPLY SIRONA is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 87.3% of UFP Technologies shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by insiders. Comparatively, 4.6% of UFP Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

UFP Technologies has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.66	-$598M	-$3.15	N/A
UFP Technologies	$602.80M	4.03	$68.31M	$9.28	33.84

Summary

UFP Technologies beats DENTSPLY SIRONA on 10 of the 15 factors compared between the two stocks.

Get UFP Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UFPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UFPT vs. The Competition

Export

Metric	UFP Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.43B	$5.86B	$7.03B	$13.02B
Dividend Yield	N/A	1.78%	2.58%	10.20%
P/E Ratio	33.84	24.26	271.36	25.17
Price / Sales	4.03	62.02	591.60	84.15
Price / Cash	25.42	33.10	71.81	50.72
Price / Book	5.25	5.70	13.25	6.22
Net Income	$68.31M	$148.58M	$3.45B	$342.66M
7 Day Performance	23.25%	4.75%	4.67%	4.41%
1 Month Performance	24.84%	1.35%	-0.79%	-0.28%
1 Year Performance	52.76%	4.94%	76.94%	22.60%

UFP Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UFPT UFP Technologies	2.3722 of 5 stars	$314.01 +0.7%	N/A	+52.3%	$2.43B	$602.80M	33.84	5,349	News Coverage Earnings Report Analyst Upgrade
BLCO Bausch + Lomb	3.5321 of 5 stars	$16.79 -0.7%	$18.75 +11.7%	+21.6%	$6.04B	$5.10B	N/A	13,000	News Coverage Analyst Revision
MMSI Merit Medical Systems	3.3483 of 5 stars	$85.53 +0.6%	$100.30 +17.3%	+4.0%	$5.08B	$1.52B	35.34	7,500
NVST Envista	2.3102 of 5 stars	$27.31 flat	$28.62 +4.8%	+40.6%	$4.44B	$2.72B	66.61	12,000	News Coverage Positive News Earnings Report Analyst Forecast
ICUI ICU Medical	2.8821 of 5 stars	$172.94 +2.6%	$172.00 -0.5%	+42.1%	$4.21B	$2.16B	93.48	13,000	Trending News Earnings Report Analyst Forecast Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:UFPT) was last updated on 8/8/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UFP Technologies (UFPT) Competitors

UFPT vs. BLCO, MMSI, NVST, ICUI, and XRAY

How does UFP Technologies compare to Bausch + Lomb?

Summary

How does UFP Technologies compare to Merit Medical Systems?

Summary

How does UFP Technologies compare to Envista?

Summary

How does UFP Technologies compare to ICU Medical?

Summary

How does UFP Technologies compare to DENTSPLY SIRONA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT vs. The Competition

UFP Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

UFP Technologies (UFPT) Competitors

UFPT vs. BLCO, MMSI, NVST, ICUI, and XRAY

How does UFP Technologies compare to Bausch + Lomb?

Which has more volatility & risk, BLCO or UFPT?

Is BLCO or UFPT more profitable?

Do institutionals and insiders have more ownership in BLCO or UFPT?

Does the media refer more to BLCO or UFPT?

Do analysts rate BLCO or UFPT?

Which has preferable valuation and earnings, BLCO or UFPT?

Summary

How does UFP Technologies compare to Merit Medical Systems?

Which has better earnings and valuation, MMSI or UFPT?

Is MMSI or UFPT more profitable?

Do insiders & institutionals believe in MMSI or UFPT?

Which has more volatility and risk, MMSI or UFPT?

Does the media prefer MMSI or UFPT?

Do analysts recommend MMSI or UFPT?

Summary

How does UFP Technologies compare to Envista?

Which has more volatility & risk, NVST or UFPT?

Do analysts rate NVST or UFPT?

Is NVST or UFPT more profitable?

Do insiders & institutionals have more ownership in NVST or UFPT?

Does the media refer more to NVST or UFPT?

Which has preferable earnings & valuation, NVST or UFPT?

Summary

How does UFP Technologies compare to ICU Medical?

Which has more volatility and risk, ICUI or UFPT?

Which has better earnings and valuation, ICUI or UFPT?

Do analysts prefer ICUI or UFPT?

Do institutionals and insiders have more ownership in ICUI or UFPT?

Is ICUI or UFPT more profitable?

Does the media refer more to ICUI or UFPT?

Summary

How does UFP Technologies compare to DENTSPLY SIRONA?

Is XRAY or UFPT more profitable?

Does the media prefer XRAY or UFPT?

Which has more volatility & risk, XRAY or UFPT?

Do analysts prefer XRAY or UFPT?

Do institutionals & insiders believe in XRAY or UFPT?

Which has preferable valuation & earnings, XRAY or UFPT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT vs. The Competition

UFP Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools